Thousand Oaks-based biomedical firm Amgen said this week that it has appointed a new president of its Japanese subsidiary Amgen KK. Yuki Orihara has been appointed as President and Representative Director of Amgen KK, the firm's wholly owned subsidiary. Orihara will head all of Amgen's commercial efforts in Japan, and will be based in Tokyo. Orihara joins the firm from Novartis Pharma KK. Amgen employes 120 in Japan. More information »